Warfarin Sodium tablets

Company
Barr Laboratories

Approval Status
Approved March 1997

Treatment for
Anticoagulant, or ""blood thinner"" to keep blood clots from forming or getting larger

Areas
Cardiovascular / Cardiology

Seven strengths of Warfarin Sodium tablets, the generic equivalent of DuPont Merck’s anti-coagulant Coumadin, have been approved for marketing.

Warfarin_sodium_tablets Drug Information

The Warfarin_sodium_tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top